Phoenux

Phoenux is a biotechnology company dedicated to reversing aging and treating age-related diseases through the development of therapies that target the root causes of biological decline. The company focuses on key hallmarks of aging, including cellular senescence, mitochondrial dysfunction, and epigenetic instability, to extend healthy human lifespan. Phoenux is currently advancing a pipeline of pre-clinical programs, with a primary emphasis on senolytic therapies designed to selectively eliminate senescent cells. By integrating cutting-edge research in longevity science with innovative drug development strategies, Phoenux aims to transform the treatment of chronic conditions associated with aging.